Galera Therapeutics stockholders elect two Class III directors, ratify KPMG as auditor

Galera Therapeutics, Inc.

Dr. Emmett Cunningham and Dr. J. Mel Sorensen elected as Class III directors with ~10.6M and ~10.7M votes for, respectively.
KPMG LLP ratified as independent auditor for FY2022 with 17,167,149 votes for, 46,053 against, and 9,939 abstained.
Approximately 64.21% of outstanding shares (17,223,141) were present or represented at the annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.